A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus
Conditions: Heart Aneurysm Interventions: Drug: Superparamagnetic Iron Oxide Nanoparticles Sponsors: The First Affiliated Hospital with Nanjing Medical University; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: AP026 (TQA2226) for injection; Drug: AP026 (TQA2226) for injection matching placebo Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
Conditions: Non Small Cell Lung Cancer Interventions: Drug: Efgbemalenograstim alfa Sponsors: Tianjin Medical University Cancer Institute and Hospital; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects
Conditions: Biliary Carcinoma Interventions: Drug: TQB3454 tablets Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects
Conditions: Pharmacokinetic Interventions: Drug: Lanifibranor Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
Conditions: Myelofibrosis Interventions: Drug: TQ05105 Tablets; Drug: TQB3617 Capsules Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
Conditions: Solid Tumor Interventions: Drug: TQB2450 injection; Drug: AL2846 capsule; Drug: Pemetrexed disodium for injection; Drug: Cisplatin injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
Conditions: Breast Cancer Interventions: Drug: TQB2102 for injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Conditions: Mantle Cell Lymphoma Interventions: Drug: 400mg of TQB3909 tablets; Drug: 600mg of TQB3909 tablets Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.
Conditions: Sinusitis Interventions: Drug: 300mg of TQH2722 injection; Drug: 600mg of TQH2722 injection; Drug: TQH2722 injection matching placebo Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics of TQA3038 Injection in Healthy Adult Subjects
Conditions: Chronic Hepatitis b Interventions: Drug: TQA3038 injection; Drug: TQA3038 injection matching placebo Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects
Conditions: Chronic Hepatitis b Interventions: Drug: TQA3038 injection; Drug: TQA3038 injection matching placebo Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain
Conditions: Endometriosis Interventions: Drug: Elagolix; Drug: Elagolix placebo Sponsors: Nanjing Chia-tai Tianqing Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients
Conditions: Diabetes; Magnetic Resonance Imaging Interventions: Drug: Polysaccharide superparamagnetic iron oxide injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies
Condition: Relapsed/Refractory Acute Myeloid Leukemia (AML) Intervention: Drug: NTQ2494 tablet Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
